Related Experiment Video
Updated: Nov 26, 2025

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Pseudomonas Aeruginosa: Genetic Adaptation, A Strategy for its Persistence in Cystic Fibrosis
Roberto Rosales-Reyes1, Silvia Yalid Vargas-Roldán1, José Luis Lezana-Fernández2
1Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.
Insights
Cystic fibrosis (CF) involves mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, leading to sticky mucus and chronic lung infections. This study details how Pseudomonas aeruginosa adapts to persist in CF lungs.
Area of Science:
- Pulmonary Medicine
- Genetics
- Microbiology
Background:
- Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, primarily the lungs and digestive system.
- CF results from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, causing dysfunctional electrolyte transport and thick mucus.
- This sticky mucus promotes chronic bacterial infections, leading to progressive lung function decline.
Purpose of the Study:
- To elucidate the adaptive mechanisms employed by Pseudomonas aeruginosa.
- To understand how P. aeruginosa persists in the unique environment of cystic fibrosis lungs.
Main Methods:
- The study likely involves microbiological and molecular techniques to analyze P. aeruginosa isolates from CF patients.
- Analysis of bacterial adaptation strategies, including biofilm formation and immune evasion.
Main Results:
- P. aeruginosa exhibits specific adaptations to survive and proliferate in the CF lung.
- These adaptations are crucial for the pathogen's persistence throughout the patient's life.
Conclusions:
- Understanding P. aeruginosa adaptation mechanisms is key to developing targeted therapies for CF lung infections.
- Further research into these mechanisms could lead to improved treatment strategies for cystic fibrosis patients.
Abstract:
Cystic fibrosis (CF) is a progressive autosomal recessive genetic disease that principally affects the respiratory and digestive systems. It is a chronic disease that has no cure. Symptoms often include chronic cough, lung infections, and shortness of breath. Children with cystic fibrosis present failure to thrive as manifested by low weight and height for age. CF is caused by mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene that codes for a cell membrane protein of epithelial tissues and affects multiple organ systems in the human body. Mutations on the CFTR causes dysfunctional electrolyte regulation affecting intracellular water content. Defective CFTR function in airways produce a dehydrated and sticky mucus that leads the establishment of bacterial chronic infection that ultimate decrease the lung function. During the first decade of life, affected individuals are colonized principally by non typable Haemophilus influenzae and Staphylococcus aureus. During the second decade, Pseudomonas aeruginosa becomes the most dominant pathogen and persists throughout the remainder of their lives. In this work, we describe the mechanisms used by P. aeruginosa to adapt and persist in lungs of individuals with cystic fibrosis.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Transduction
Cystic Fibrosis: Management
Sinus disease and chronic...

